Abstract:Objective: To analyze the factors related to Helicobacter pylori (Hp) infection in patients with severe acute pancreatitis (SAP) and to observe the effect of Hp on SAP, and to provide a reference for future clinical prevention and treatment of Hp infection in SAP. Methods: A retrospective analysis was performed on 77 SAP patients admitted to Pingxiang People's Hospital between January 2020 and February 2022, with 33 Hp-infected individuals as the Hp-positive group and the other 44 patients being without Hp infection served as the Hp-negative group. First, the related factors of Hp infection in SAP patients were analyzed with multiple Logistic regression. Subsequently, the Acute Physiology and Chronic Health Evaluation II (APACHE II), Bedside Index for Severity in Acute Pancreatitis (BISAP) and Modified CT Severity Index (MCTSI) scores, as well as the levels of C-reactive protein (CRP), white blood cell (WBC), procalcitonin (PCT) and immunoglobulins A/M/G (IgA, IgM, and IgG) were recorded for inter-group comparisons. The adverse reactions and hospitalization time were also recorded. Besides, a six-month follow-up was carried out after discharge, and patients' quality of life was evaluated using the Short-Form 36 Item Health Survey (SF-36). Results: Logistic regression analysis identified that history of Hp infection, long-term drinking, eating habits and history of biliary tract diseases were independent risk factors for Hp infection (all P<0.05). At 2 weeks after admission, higher APACHE II, BISAP and MCTSI scores were observed in Hp-positive group compared with Hp-negative group (all P<0.05). The Hp-positive group exhibited higher CRP, WBC and PCT levels while lower IgA, IgM and IgG levels during treatment compared to the Hp-negative group (all P<0.05). No difference was found in the incidence of adverse reactions between the two groups (P>0.05), but the hospitalization time of the Hp-positive group was significantly prolonged (P<0.05). The follow-up results determined better quality of life in the Hp-negative group, which resulted in higher SF-36 scores in various dimensions (P<0.05). Conclusion: The history of Hp infection, long-term drinking, eating habits, and history of biliary tract diseases are all independent risk factors for Hp infection. Hp infection exacerbates disease progression of SAP, adversely influences patients' recovery, impairs their immune function, and compromises their prognoses.

Incidence, prevalence, and comorbidities of chronic pancreatitis: A 7-year population-based study

The Relationship between Helicobacter pylori and Inflammatory Bowel Disease Based on Epidemiological Data: A Systematic Review and Meta-Analysis

Diagnostic value of conventional endoscopic ultrasound for lymph node metastasis in upper gastrointestinal neoplasia: A meta-analysis

Immune response modulation in inflammatory bowel diseases by Helicobacter pylori infection

Exploring the regulatory mechanism of tRNA-derived fragments 36 in acute pancreatitis based on small RNA sequencing and experiments

Helicobacter Pylori Infection of the Gallbladder and the Risk of Chronic Cholecystitis and Cholelithiasis: A Systematic Review and Meta-Analysis.

Correlation Between Helicobacter Pylori Infection and Crohn's Disease: a Meta-Analysis

Helicobacter Pylori Colonization Protects Against Chronic Experimental Colitis By Regulating Th17/Treg Balance

Helicobacter pylori: Does Gastritis Prevent Colitis?

Helicobacter Pylori Infection Is Associated With The Presence Of Thyroid Nodules In The Euthyroid Population

The Impact of Helicobacter Pylori Infection, Eradication Therapy and Probiotic Supplementation on Gut Microenvironment Homeostasis: an Open-Label, Randomized Clinical Trial

Helicobacter pylori in Inflammatory Bowel Diseases: Active Protagonist or Innocent Bystander?

Is Helicobacter pylori infection associated with pancreatic cancer? A systematic review and meta-analysis of observational studies

Diagnosis of Helicobacter Pylori Infection is Associated with Lower Prevalence and Subsequent Incidence of Crohn's Disease

Fecal microbiota transplantation alleviates experimental colitis through the Toll-like receptor 4 signaling pathway

Does Helicobacter pylori eradication therapy trigger or protect against Crohn's disease?

H.pylori Infection Alleviates Acute and Chronic Colitis with the Expansion of Regulatory B Cells in Mice

Analysis of factors associated with Helicobacter pylori infection in severe pancreatitis patients and its effect on patient's prognosis

Bibliometric analysis of the correlation between H. pylori and inflammatory bowel disease

Immunological relationship between Helicobacter pylori and anti-tumor necrosis factor α agents in inflammatory bowel disease

Helicobacter Pylori Seropositivities and Risk of Pancreatic Carcinoma.